The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Cannabinoids promote embryonic and adult hippocampus neurogenesis and produce anxiolytic- and antidepressant-like effects
Open accessAbstract
The hippocampal dentate gyrus in the adult mammalian brain contains neural stem/progenitor cells (NS/PCs) capable of generating new neurons, i.e., neurogenesis. Most drugs of abuse examined to date decrease adult hippocampal neurogenesis, but the effects of cannabis (marijuana or cannabinoids) on hippocampal neurogenesis remain unknown. This study aimed at investigating the potential regulatory capacity of the potent synthetic cannabinoid HU210 on hippocampal neurogenesis and its possible correlation with behavioral change. We show that both embryonic and adult rat hippocampal NS/PCs are immunoreactive for CB1 cannabinoid receptors, indicating that cannabinoids could act on CB1 receptors to regulate neurogenesis. This hypothesis is supported by further findings that HU210 promotes proliferation, but not differentiation, of cultured embryonic hippocampal NS/PCs likely via a sequential activation of CB1 receptors, G(i/o) proteins, and ERK signaling. Chronic, but not acute, HU210 treatment promoted neurogenesis in the hippocampal dentate gyrus of adult rats and exerted anxiolytic- and antidepressant-like effects. X-irradiation of the hippocampus blocked both the neurogenic and behavioral effects of chronic HU210 treatment, suggesting that chronic HU210 treatment produces anxiolytic- and antidepressant-like effects likely via promotion of hippocampal neurogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants
Santarelli, L., Saxe, M., Gross, C., Surget, A., Battaglia, F., Dulawa, S., Weisstaub, N., Lee, J., Duman, R., Arancio, O., et al. (2003) · Science · doi:10.1126/science.1083328 · Cited by 4,321
Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus
Malberg, J. E., Eisch, A. J., Nestler, E. J., & Duman, R. S. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-24-09104.2000 · Cited by 3,111
Functional neurogenesis in the adult hippocampus
van Praag, H., Schinder, A. F., Christie, B. R., Toni, N., Palmer, T. D., & Gage, F. H. (2002) · Nature · doi:10.1038/4151030a · Cited by 2,853
Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system
Tsou, K., Brown, S., Sañudo-Peña, M. C., Mackie, K., & Walker, J. M. (1998) · Neuroscience · doi:10.1016/s0306-4522(97)00436-3 · Cited by 1,586
Adult neurogenesis produces a large pool of new granule cells in the dentate gyrus
Cameron, H. A., & Mckay, R. D. G. (2001) · Journal of Comparative Neurology · doi:10.1002/cne.1040 · Cited by 1,585
Assessing antidepressant activity in rodents: recent developments and future needs
Cryan, J. F., Markou, A., & Lucki, I. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(02)02017-5 · Cited by 1,551 · cited 2×
“This is unlikely, however, as we observed no significant difference in the number of rats climbing (41, 42) among HU210-, AM281-, and vehicle-treated groups in the first 5 minutes of the pretest sessions of the FST.”
BackgroundMethodMilestones of neuronal development in the adult hippocampus
Kempermann, G., Jessberger, S., Steiner, B., & Kronenberg, G. (2004) · Trends in Neurosciences · doi:10.1016/j.tins.2004.05.013 · Cited by 1,460
Reynolds, B. A., & Weiss, S. (1996) · Developmental Biology · doi:10.1006/dbio.1996.0090 · Cited by 1,368
Gritti, A., Parati, E. A., Cova, L., Frolichsthal, P., Galli, R., Wanke, E., Faravelli, L., Morassutti, D. J., Roisen, F. J., Nickel, D. D., et al. (1996) · Journal of Neuroscience · doi:10.1523/jneurosci.16-03-01091.1996 · Cited by 1,029
Kempermann, G., Gast, D., Kronenberg, G., Yamaguchi, M., & Gage, F. H. (2002) · Development · doi:10.1242/dev.00203 · Cited by 1,003
Flagged first, then by citations
Cited by
Sorted by citations
Mechanisms and Functional Implications of Adult Neurogenesis
Zhao, C., Deng, W., & Gage, F. H. (2008) · Cell · doi:10.1016/j.cell.2008.01.033 · Cited by 3,007
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
Pacher, P., Bátkai, S., & Kunos, G. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.2 · Cited by 2,077
Adult neurogenesis and functional plasticity in neuronal circuits
Lledo, P., Alonso, M., & Grubb, M. S. (2006) · Nature reviews. Neuroscience · doi:10.1038/nrn1867 · Cited by 1,425
Adult hippocampal neurogenesis in depression
Sahay, A., & Hen, R. (2007) · Nature Neuroscience · doi:10.1038/nn1969 · Cited by 1,206
Synthetic cannabinoids: Epidemiology, pharmacodynamics, and clinical implications
Castaneto, M. S., Gorelick, D. A., Desrosiers, N. A., Hartman, R. L., Pirard, S., & Huestis, M. A. (2014) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2014.08.005 · Cited by 710
Stress, serotonin, and hippocampal neurogenesis in relation to depression and antidepressant effects
Mahar, I., Bambico, F. R., Mechawar, N., & Nobrega, J. N. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.11.009 · Cited by 694
Hippocampal Neurogenesis: Regulation by Stress and Antidepressants
Dranovsky, A., & Hen, R. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.03.082 · Cited by 663
Neurobiological Interactions Between Stress and the Endocannabinoid System
Morena, M., Patel, S., Bains, J. S., & Hill, M. N. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.166 · Cited by 698
Surget, A., Saxe, M., Leman, S., Ibarguen-Vargas, Y., Chalon, S., Griebel, G., Hen, R., & Belzung, C. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.02.022 · Cited by 556
The neurobiology of depression and antidepressant action
Willner, P., Scheel-Krüger, J., & Belzung, C. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.12.007 · Cited by 519
Gao, Y., Vasilyev, D. V., Goncalves, M. B., Howell, F. V., Hobbs, C., Reisenberg, M., Shen, R., Zhang, M.-Y., Strassle, B. W., Lu, P., et al. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.5693-09.2010 · Cited by 473
Campos, A. C., Moreira, F. A., Gomes, F. V., Del Bel, E. A., & Guimarães, F. S. (2012) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2011.0389 · Cited by 475
Antidepressants recruit new neurons to improve stress response regulation
Surget, A., Tanti, A., Leonardo, E. D., Laugeray, A., Rainer, Q., Touma, C., Palme, R., Griebel, G., Ibarguen-Vargas, Y., Hen, R., et al. (2011) · Molecular Psychiatry · doi:10.1038/mp.2011.48 · Cited by 471
The emerging functions of endocannabinoid signaling during CNS development
Harkany, T., Guzmán, M., Galve‐Roperh, I., Berghuis, P., Devi, L. A., & Mackie, K. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.12.004 · Cited by 449
Balu, D. T., & Lucki, I. (2008) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2008.08.007 · Cited by 395
Endocannabinoid signalling and the deteriorating brain
Marzo, V. D., Stella, N., & Zimmer, A. (2014) · Nature reviews. Neuroscience · doi:10.1038/nrn3876 · Cited by 395
Cannabinoid Receptors in the Central Nervous System: Their Signaling and Roles in Disease
Kendall, D. A., & Yudowski, G. A. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2016.00294 · Cited by 388
Cannabis and adolescent brain development.
Lubman, D. I., Cheetham, A., & Yücel, M. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.11.009 · Cited by 360
Bortolato, M., Mangieri, R. A., Fu, J., Kim, J. H., Arguello, O., Duranti, A., Tontini, A., Mor, M., Tarzia, G., & Piomelli, D. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.12.001 · Cited by 347
Zuena, A. R., Mairesse, J., Casolini, P., Cinque, C., Alemà, G., Morley‐Fletcher, S., Chiodi, V., Spagnoli, L. G., Gradini, R., Catalani, A., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002170 · Cited by 353
Spice drugs as a new trend: Mode of action, identification and legislation
Vardakou, I., Pistos, C. M., & Spiliopoulou, C. (2010) · Toxicology Letters · doi:10.1016/j.toxlet.2010.06.002 · Cited by 341
Chevalier, G., Siopi, E., Guenin‐Macé, L., Pascal, M., Laval, T., Rifflet, A., Boneca, I. G., Demangel, C., Colsch, B., Pruvost, A., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19931-2 · Cited by 337
Bambico, F. R., Katz, N., Debonnel, G., & Gobbi, G. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.1636-07.2007 · Cited by 325
Campos, A. C., Ortega, Z., Palazuelos, J., Fogaça, M. V., Aguiar, D. C., Díaz-Alonso, J., Ortega-Gutiérrez, S., Vázquez-Villa, H., Moreira, F. A., Guzmán, M., et al. (2013) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145712001502 · Cited by 313
The Endocannabinoid System: A Potential Target for the Treatment of Various Diseases
Lowe, H., Toyang, N., Steele, B., Bryant, J., & Ngwa, W. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179472 · Cited by 303
Programming of neural cells by (endo)cannabinoids: from physiological rules to emerging therapies
Maccarrone, M., Guzmán, M., Mackie, K., Doherty, P., & Harkany, T. (2014) · Nature Reviews Neuroscience · doi:10.1038/nrn3846 · Cited by 298
Neurogenesis and affective disorders
Samuels, B. A., & Hen, R. (2011) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2011.07614.x · Cited by 303
Fraser, G. A. (2009) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2008.00071.x · Cited by 283
Cannabinoid receptor signaling in progenitor/stem cell proliferation and differentiation
Galve‐Roperh, I., Chiurchiù, V., Díaz-Alonso, J., Bari, M., Guzmán, M., & Maccarrone, M. (2013) · Progress in Lipid Research · doi:10.1016/j.plipres.2013.05.004 · Cited by 287
Moreira, F. A., Kaiser, N., Monory, K., & Lutz, B. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.07.005 · Cited by 288
Best Practice & Research Clinical Endocrinology & Metabolism
Grieb, M. (2009) · Cited by 276
Moreira, F. A., Grieb, M., & Lutz, B. (2009) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2008.09.003 · Cited by 277
El‐Alfy, A. T., Ivey, K., Robinson, K., Ahmed, S. A., Radwan, M. M., Slade, D., Khan, I. A., ElSohly, M. A., & Ross, S. A. (2010) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2010.03.004 · Cited by 278
The Endocannabinoid System Promotes Astroglial Differentiation by Acting on Neural Progenitor Cells
Aguado, T., Palazuelos, J., Monory, K., Stella, N., Cravatt, B. F., Lutz, B., Marsicano, G., Kokaia, Z., Guzmán, M., & Galve‐Roperh, I. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.3101-05.2006 · Cited by 269
Pharmacology, Toxicology, and Adverse Effects of Synthetic Cannabinoid Drugs.
Gurney, S. M. R., Scott, K. S., Kacinko, S. L., Presley, B. C., & Logan, B. K. (2014) · PubMed · Cited by 257
Petrik, D., Lagace, D. C., & Eisch, A. J. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.09.003 · Cited by 241
Beyond the Hippocampus and the SVZ: Adult Neurogenesis Throughout the Brain
Jurkowski, M. P., Bettio, L. E. B., Woo, E. K., Patten, A. R., Yau, S., & Gil‐Mohapel, J. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.576444 · Cited by 278
Medial temporal structures and memory functions in adolescents with heavy cannabis use
Ashtari, M., Avants, B., Cyckowski, L. L., Cervellione, K. L., Roofeh, D., Cook, P. A., Gee, J. C., Sevy, S. M., & Kumra, S. (2011) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2011.01.004 · Cited by 251
Olfaction: A potential cognitive marker of psychiatric disorders
Atanasova, B., Graux, J., El‐Hage, W., Hommet, C., Camus, V., & Belzung, C. (2008) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2008.05.003 · Cited by 252
Leptin Increases Adult Hippocampal Neurogenesis in Vivo and in Vitro
Garza, J. C., Guo, M., Zhang, W., & Lu, X. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800053200 · Cited by 241
Zhu, X.-H., Yan, H., Zhang, J., Qu, H.-D., Qiu, X., Chen, L., Li, S.-J., Cao, X., Bean, J. C., Chen, L. H., et al. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.6414-09.2010 · Cited by 229
Shen, C.-J., Zheng, D., Li, K., Yang, J., Pan, H., Yu, X.-D., Fu, J., Zhu, Y., Sun, Q.-X., Tang, M., et al. (2019) · Nature Medicine · doi:10.1038/s41591-018-0299-9 · Cited by 231
Zhou, Q., Hu, Y., Hua, Y., Hu, M., Luo, C., Han, X., Zhu, X., Wang, B., Xu, J., & Zhu, D. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04914.x · Cited by 225
Endocannabinoid system and mood disorders: Priming a target for new therapies
Micale, V., Marzo, V. D., Šulcová, A., Wotjak, C. T., & Drago, F. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.12.002 · Cited by 224
Segi‐Nishida, E., Warner‐Schmidt, J. L., & Duman, R. S. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710858105 · Cited by 227
Non‐psychoactive CB 2 cannabinoid agonists stimulate neural progenitor proliferation
Palazuelos, J., Aguado, T., Egia, A., Mechoulam, R., Guzmán, M., & Galve‐Roperh, I. (2006) · The FASEB Journal · doi:10.1096/fj.06-6164fje · Cited by 222
The endocannabinoid system: emotion, learning and addiction
Moreira, F. A., & Lutz, B. (2008) · Addiction Biology · doi:10.1111/j.1369-1600.2008.00104.x · Cited by 233
Cannabis and psychiatric disorders: it is not only addiction
Leweke, F. M., & Koethe, D. (2008) · Addiction Biology · doi:10.1111/j.1369-1600.2008.00106.x · Cited by 213
Wolf, S. A., Bick-Sander, A., Fabel, K., Leal-Galicia, P., Tauber, S., Ramirez-Rodriguez, G., Müller, A., Melnik, A., Waltinger, T. P., Ullrich, O., et al. (2010) · Cell Communication and Signaling · doi:10.1186/1478-811x-8-12 · Cited by 208
Tchantchou, F., Xu, Y., Wu, Y., Christen, Y., & Luo, Y. (2007) · The FASEB Journal · doi:10.1096/fj.06-7649com · Cited by 203
Cannabis and cognitive dysfunction: Parallels with endophenotypes of schizophrenia?
Solowij, N., & Michie, P. T. (2007) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0705 · Cited by 202
Wu, C., Jew, C. P., & Lu, H. (2011) · Future Neurology · doi:10.2217/fnl.11.27 · Cited by 202
Adult Neurogenesis and Mental Illness
Schoenfeld, T. J., & Cameron, H. A. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.230 · Cited by 192
Exercise-induced endocannabinoid signaling is modulated by intensity
Raichlen, D. A., Foster, A. D., Seillier, A., Giuffrida, A., & Gerdeman, G. L. (2013) · European Journal of Applied Physiology · doi:10.1007/s00421-012-2495-5 · Cited by 181
Endocannabinoid influence in drug reinforcement, dependence and addiction-related behaviors
Serrano, A., & Parsons, L. H. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.06.005 · Cited by 188
Goncalves, M. B. C. V., Suetterlin, P., Yip, P. K., Molina‐Holgado, F., Walker, D. J., Oudin, M. J., Zentar, M. P., Pollard, S. M., Yáñez‐Muñoz, R. J., Williams, G. H., et al. (2008) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2008.05.001 · Cited by 177
Campos, A. C., Fogaça, M. V., Scarante, F. F., Joca, S. R. L., Sales, A. J., Gomes, F. V., Sonego, A. B., Rodrigues, N. S., Galve-Roperh, I., & Guimarães, F. S. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00269 · Cited by 175
Xu, H., Chen, Z., He, J., Haimanot, S., Li, X., Dyck, L. E., & Li, X. (2006) · Hippocampus · doi:10.1002/hipo.20184 · Cited by 175
Hill, M. N., Hillard, C. J., Bambico, F. R., Patel, S., Gorzalka, B. B., & Gobbi, G. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.06.006 · Cited by 175
Cameron, C., Watson, D. B., & Robinson, J. (2014) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000180 · Cited by 179
Soumier, A., Banasr, M., Lortet, S., Masmejean, F., Bernard, N., Goff, L. K., Gabriel, C., Millan, M. J., Mocaër, E., & Daszuta, A. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.72 · Cited by 175
Montero‐Pedrazuela, A., Venero, C., Lavado-Autric, R., Fernández‐Lamo, I., García‐Verdugo, J. M., Bernal, J., & Guadaño‐Ferraz, A. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001802 · Cited by 175
Role of the endocannabinoid system in regulation of the hypothalamic-pituitary-adrenocortical axis
Steiner, M. S., & Wotjak, C. T. (2008) · Progress in brain research · doi:10.1016/s0079-6123(08)00433-0 · Cited by 174
Aguado, T., Romero, E., Monory, K., Palazuelos, J., Sendtner, M., Marsicano, G., Lutz, B., Guzmán, M., & Galve‐Roperh, I. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700678200 · Cited by 170
Thakker‐Varia, S., Krol, J. G., Nettleton, J., Bilimoria, P. M., Bangasser, D. A., Shors, T. J., Black, I. B., & Alder, J. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.1898-07.2007 · Cited by 169
Acute administration of leptin produces anxiolytic-like effects: a comparison with fluoxetine
Liu, J., Garza, J. C., Bronner, J., Kim, C. S., Zhang, W., & Lu, X. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1684-3 · Cited by 165
Ma, H., Li, C., Wang, J., Zhang, X., Li, M., Zhang, R., Huang, Z., & Zhang, Y. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2019409118 · Cited by 163
Inhibition of Class II Histone Deacetylases in the Spinal Cord Attenuates Inflammatory Hyperalgesia
Bai, G., Wei, D., Zou, S., Ren, K., & Dubner, R. A. (2010) · Molecular Pain · doi:10.1186/1744-8069-6-51 · Cited by 163
Legal highs: staying on top of the flood of novel psychoactive substances
Baumeister, D., Tojo, L. M., & Tracy, D. K. (2015) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125314559539 · Cited by 162
Depression, stress, epilepsy and adult neurogenesis
Danzer, S. C. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.05.023 · Cited by 157
González‐Cuevas, G., Martin‐Fardon, R., Kerr, T. M., Stouffer, D. G., Parsons, L. H., Hammell, D. C., Banks, S. L., Stinchcomb, A. L., & Weiss, F. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0050-8 · Cited by 165
Fournier, N. M., & Duman, R. S. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.04.022 · Cited by 159
The endocannabinoid receptor, CB1, is required for normal axonal growth and fasciculation
Watson, S., Chambers, D., Hobbs, C., Doherty, P., & Graham, A. (2008) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2008.02.001 · Cited by 154
The diacylglycerol lipases: structure, regulation and roles in and beyond endocannabinoid signalling
Reisenberg, M., Singh, P. K., Williams, G. H., & Doherty, P. (2012) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2011.0387 · Cited by 154
The endocannabinoid system and psychiatric disorders
Parolaro, D., Realini, N., Viganò, D., Guidali, C., & Rubino, T. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2010.03.018 · Cited by 151
Isacson, R., Nielsen, E. I., Dannaeus, K., Bertilsson, G., Patrone, C., Zachrisson, O., & Wikström, L. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.10.008 · Cited by 153
Understanding the Molecular Aspects of Tetrahydrocannabinol and Cannabidiol as Antioxidants
Borges, R. S., Batista, J., Viana, R. B., Gonçalves, A. C. B., Orestes, E., de Andrade, M. A., Honorio, K. M., & da Silva, A. B. F. (2013) · Molecules · doi:10.3390/molecules181012663 · Cited by 150
Choi, Y., Cho, H., Hoyt, K. R., Naegele, J. R., & Obrietan, K. H. (2008) · Glia · doi:10.1002/glia.20653 · Cited by 151
The Endocannabinoid System of Animals
Silver, R. (2019) · Animals · doi:10.3390/ani9090686 · Cited by 171
Born this way: Hippocampal neurogenesis across the lifespan
Kozareva, D. A., Cryan, J. F., & Nolan, Y. M. (2019) · Aging Cell · doi:10.1111/acel.13007 · Cited by 155
Christie, K. J., & Turnley, A. M. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2012.00070 · Cited by 152
Dysfunctional hippocampal activity affects emotion and cognition in mood disorders
Femenía, T., Gómez-Galán, M., Lindskog, M., & Magara, S. (2012) · Brain Research · doi:10.1016/j.brainres.2012.03.053 · Cited by 143
Prenatal cannabis exposure - The “first hit” to the endocannabinoid system
Richardson, K. A., Hester, A. K., & McLemore, G. L. (2016) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2016.08.003 · Cited by 145
Endocannabinoid System and Synaptic Plasticity: Implications for Emotional Responses
Viveros, M., Marco, E. M., Llorente, R., & López‐Gallardo, M. (2007) · Neural Plasticity · doi:10.1155/2007/52908 · Cited by 151
Nollet, M., Gaillard, P., Tanti, A., Girault, V., Belzung, C., & Leman, S. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.70 · Cited by 146
Zhong, P., Wang, W., Pan, B., Liu, X., Zhang, Z., Long, J. Z., Zhang, H., Cravatt, B. F., & Liu, Q.-S. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.24 · Cited by 137
Haspula, D., & Clark, M. A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207693 · Cited by 148
Alzheimer's disease; taking the edge off with cannabinoids?
Campbell, V. A., & Gowran, A. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707446 · Cited by 132
Hill, M. N., Titterness, A. K., Morrish, A. C., Carrier, E. J., Lee, T. T. ‐., Gil‐Mohapel, J., Gorzalka, B. B., Hillard, C. J., & Christie, B. R. (2009) · Hippocampus · doi:10.1002/hipo.20647 · Cited by 134
The role of cannabinoids in adult neurogenesis
Prenderville, J. A., Kelly, A. M., & Downer, E. J. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13186 · Cited by 136
The Endocannabinoid System and Neurogenesis in Health and Disease
Galve‐Roperh, I., Aguado, T., Palazuelos, J., & Guzmán, M. (2007) · The Neuroscientist · doi:10.1177/1073858406296407 · Cited by 129
Endothelial cell toll‐like receptor 4 regulates fibrosis‐associated angiogenesis in the liver†
Jagavelu, K., Routray, C., Shergill, U., O’Hara, S. P., Faubion, W., & Shah, V. H. (2010) · Hepatology · doi:10.1002/hep.23739 · Cited by 130
Molecular aspects of depression: A review from neurobiology to treatment
Boas, G. R. V., de Lacerda, R. B., Paes, M. M., Gubert, P., Almeida, W. L. D. C., Rescia, V. C., Galdino, P. M., de Carvalho, A. A. V., & Oesterreich, S. A. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.02.024 · Cited by 140
Biphasic effects of THC in memory and cognition
Calabrese, E. J., & Rubio‐Casillas, A. (2018) · European Journal of Clinical Investigation · doi:10.1111/eci.12920 · Cited by 132
Wang, W., Sun, D., Pan, B., Roberts, C. J., Sun, X., Hillard, C. J., & Liu, Q.-S. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.99 · Cited by 127
N-Docosahexaenoylethanolamide promotes development of hippocampal neurons
Kim, H., Moon, H., Cao, D., Lee, J., Kevala, K., Jun, S. B., Lovinger, D. M., Akbar, M. D., & Huang, B. X. (2011) · Biochemical Journal · doi:10.1042/bj20102118 · Cited by 123
Cannabis induces different cognitive changes in schizophrenic patients and in healthy controls
Jockers-Scherübl, M. C., Wolf, T., Radzei, N., Schlattmann, P., Rentzsch, J., de Castro, A. G.-C., & Kühl, K.-P. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.03.006 · Cited by 119
Medical Marijuana Laws and Suicides by Gender and Age
Anderson, D. M., Rees, D. I., & Sabia, J. J. (2014) · American Journal of Public Health · doi:10.2105/ajph.2013.301612 · Cited by 121
Mechanisms of Control of Neuron Survival by the Endocannabinoid System
Galve‐Roperh, I., Aguado, T., Palazuelos, J., & Guzmán, M. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208785740117 · Cited by 120
Gorzalka, B. B., & Hill, M. N. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.11.021 · Cited by 120
Metadata
- Authors
- Jiang, W.
- Venue
- Journal of Clinical Investigation
- Published
- 2005-11-01
- Volume
- 115
- Issue
- 11
- Pages
- 3104-3116
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC1253627
- OpenAlex
- W2097448914
- Cited by
- 527
- References
- 62
- Citations by year
- 2026: 6 · 2025: 10 · 2024: 18 · 2023: 17 · 2022: 16 · 2021: 30 · 2020: 24 · 2019: 23 · 2018: 19 · 2017: 18 · 2016: 19 · 2015: 27 · 2014: 39 · 2013: 33 · 2012: 33
- FWCI
- 20.20
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- public-domain
- Locations
- Journal of Clinical Investigation (publishedVersion, public-domain)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Heart and Stroke Foundation of Canada
- Saskatchewan Health Research Foundation
- Canadian Institutes of Health Research
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- cannabinoids, HU-210, CB1 receptor, adult hippocampal neurogenesis, dentate gyrus, neural stem/progenitor cells, anxiolytic effects, antidepressant-like effects, ERK signaling, G protein signaling
- MeSH terms
- Animals, Antidepressive Agents, Arachidonic Acids, Cannabinoids, Cells, Cultured, Hippocampus, Male, Neurons, Rats, Inbred F344, Stem Cells, Dronabinol, Anti-Anxiety Agents, Signal Transduction, Rats, Wistar, Rats, Long-Evans, Receptor, Cannabinoid, CB1, Cell Proliferation, Rats, Polyunsaturated Alkamides, Endocannabinoids
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review